Eli Lilly's Orforglipron Beats Novo Nordisk's GLP-1 Pill in Tests

Eli Lilly's Orforglipron Beats Novo Nordisk's GLP-1 Pill in Tests

Business Insider business

Key Points:

  • Better injections and better pills. It's official: Eli Lilly appears to be beating Novo Nordisk at the weight loss game.
  • On Thursday, Lilly announced that its forthcoming GLP-1 pill, called orforglipr

Trending Business

Trending Technology

Trending Health